Fri Aug, 15 2008
Spleen Shares Roundup
Spleenco Vice-President for Biocommerce Operations Splice Ripman was ebullient today on news that Hillary Rodham will be placed in nomination for U.S. president at the Democratic National Convention at Denver.
"This is the right moment for spleen futures!" said Ripman, pounding the lecturn in great excitement. "Spleenco's corporate strategy planners are always at work to bring the highest value to the small ductless gland sector, but market contingencies can emerge out of the black, from nowhere, and the savvy investor is always ready to take advantage. Buy Spleenco today!"
At yesterday's market close, Spleenco shares were up 126% on the announcement. Said one analyst, "When Ripman starts talking like that, I reach for my kevlar. The action on the street could be very bloody for those not in the Spleenco groove. I'd jump if I were you."